Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

著者: Gregory J. Moran, Edward Fang, G. Ralph Corey, Anita Das, Carisa De Anda, Philippe Prokocimer - The Lancet 2014 被引用: 304